Child with Suspected Short Stature

Primary Care provider guidelines for referral.

Read More

New Meds and Tech: Tandem® Diabetes Care Control-IQ Technology

In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…

Read More

Late Effects of Treatments for Childhood Cancer (NIH-National Cancer Institute)

Endocrine Late-Effects of Treatment for Childhood Cancer

Read More

Child with Suspected Hypocalcemia

Primary Care provider guidelines for referral.

Read More

New Meds and Tech: New Cortisol Assays, New Threshold for Adrenal Insufficiency

 

Read More

New Meds and Tech: Newer Insulin Preparation – Faster Insulin Aspart (Fiasp)

Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…

Read More

New Meds and Tech: Increlex

In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…

Read More

New Meds and Tech: Glucagon Preparations

The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…

Read More

New Meds and Tech: Vitamin D Preparations and Safety Issues

Vitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other…

Read More

New Meds and Tech: Tirosint-SOL

Levothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for…

Read More